Trial NCT01905592

View at ClinicalTrials.gov 
Org. Study IDs: 213551
Secondary IDs: 1307-BCG, BIG5-13 PR-30-5010-C

Last trial update was posted on 2022-11-15

MeSH Interventions

Niraparib

MeSH Conditions

Breast Neoplasms Carcinoma Neoplasms Ovarian Neoplasms

Other Conditions

BRCA1 Gene Mutation BRCA2 Gene Mutation Carcinoma of Breast Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Neoplasms, Breast

Stopping Reasons

The study was terminated due to futility.

Limitations And Caveats

IDMC interim analysis concluded that concerns with the quantity and quality of data in the control arm precluded meaningful comparative analyses and generation of a clinically useful endpoint, therefore enrollment was ended prematurely.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID